Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis Journal"
DOI: 10.1186/s12959-020-00228-9
Abstract: Rivaroxaban has the most available data to support the use of prothrombin complex concentrates (PCC) as a reversal agent. However, PCC might increase the incidence of thrombotic events by shifting the haemostatic balance towards hypercoagulability.… read more here.
Keywords: prothrombin complex; anticoagulant effect; complex concentrates; rivaroxaban anticoagulant ... See more keywords